Skip to main content
Premium Trial:

Request an Annual Quote

Hybrigenics, Dualsystems to Co-Market Yeast Two-Hybrid Screens for Membrane Proteins

NEW YORK (GenomeWeb News) – Hybrigenics said today that it has signed a co-marketing agreement with Dualsystems Biotech covering yeast two-hybrid screening services for full membrane proteins.
 
Under the terms of the agreement, both Dualsystems and Hybrigenics will commercialize Dualsystems’ DUALmembrane screens, which were designed for identifying protein interactions involving full membrane proteins.
 
Hybrigenics will perform the screens on its ISO 9001-certified yeast two-hybrid platform.
 
The companies said that the profit-sharing partnership will “boost Dualsystems' commercial and production volumes for its membrane technology.”
 
Hybrigenics is a biopharmaceutical company focused on developing cancer therapies through its Hybrigenics Pharma unit. The company also offers a range of protein-interaction screening services.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.